Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Articles   |    
Five Cases of Pigmentary Retinopathy Associated with Thioridazine Administration
Am J Psychiatry 1966;123:97-100.
View Author and Article Information

Consultant in Ophthalmology, Boston State Hospital

Senior Physician in Psychiatry, Boston State Hospital

Senior Physician in Medicine, Boston State Hospital

1966-67, American Psychiatric Association

text A A A
PDF of the full text article.

Out of a population of about 2,200 patients at Boston State Hospital in September and October of 1963, 164 patients were being treated with thioridazine. As a result of ophthalmological examination, five cases of pigmentary retinopathy were discovered in a group of eight patients who were receiving dosages of more than 1800 mg. of thioridazine and no changes were observed in those patients who received less.The five patients all presented marked chronic mental disturbances such as one is unlikely to encounter in the community. Possibly because of their confusion and disorientation, they were unable to report any subjective symptoms which they may have been experiencing, such as brownished coloration of vision and diminution of night vision. The five patients who exhibited retinal changes had been treated with thioridazine for 15 days, one month, six months, six months, and ten months respectively. All five patients had received large doses of other medications prior to the administration of thioridazine, and the possibility of cumulative or additive effects has not been ruled out.

Abstract Teaser
Figures in this Article

Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).




CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe

Web of Science® Times Cited: 21

Related Content
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 27.  >
What Your Patients Need to Know About Psychiatric Medications, 2nd Edition > Chapter 48.  >
APA Practice Guidelines > Chapter 4.  >
APA Practice Guidelines > Chapter 4.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 26.  >
Topic Collections
Psychiatric News
PubMed Articles